BioPlus Acquisition Corp. (BIOS) Stock Analysis

What BioPlus Acquisition Corp. does

Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.

Key metrics

ETFs linked to BIOS

Broad-market and Financial Services sector ETFs an investor holding BioPlus Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BIOS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for BioPlus Acquisition Corp.?

BioPlus Acquisition Corp. trades under the ticker BIOS on NASDAQ.

Which exchange is BIOS listed on?

BIOS is listed on NASDAQ.

What sector does BioPlus Acquisition Corp. operate in?

BioPlus Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze BIOS in a portfolio?

PortView shows BIOS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.